의료진프로필

Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile

Kang, DB; Park, S; Kim, HJ; Lee, JS; Han, JY; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Cho, JH; Park, YH

Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants

Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H

Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study

Kang, D; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Kim, JY; Nam, SJ; Cho, J; Park, YH

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer

Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H

A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer

Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ

The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis

Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM

Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study

Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer

Shin, J; Kim, JY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, W; Park, YH; Ahn, JS; Im, YH

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy

Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY

Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study

Kang, DB; Cho, JH; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Park, YH

Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis

Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer

Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH

Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study

Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study

Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer

Lee, H; Choi, JY; Park, YH; Lee, JE; Kim, SW; Nam, SJ; Cho, YS

Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study

Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH

Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis

Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J

Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells

Kim, S; Kim, H; Jeong, Y; You, D; Yoon, SY; Lo, EJ; Nam, SJ; Lee, JE; Kim, SW

The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection

Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH

The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial

Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay

Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW

Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?

Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, J; Kim, SW; Lee, JE; Ryu, JM; Bang, SI

Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy

Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ

ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter?

Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, JH; Kim, SW; Lee, JE; Ryu, JM; Bang, SI

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?

Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience

Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH

Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma

Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors

Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients

Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy

Kim, JY; Oh, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kim, K; Im, YH

Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea

Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE

Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society

Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE

Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients

Kwon, MR; Ko, ES; Park, MS; Jeong, WK; Hwang, NY; Kim, JH; Lee, JE; Kim, SW; Yu, JH; Han, BK; Ko, EY; Choi, JS; Park, KW

Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations

Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching

Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study

Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea

Park, YH; Karantza, V; Calhoun, SR; Park, S; Lee, S; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Nam, SJ; Aktan, G; Marsico, M

Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial

Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW

Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea

Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients

Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Entelon(R) (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Lo, E; Kim, SW; Lee, JE; Nam, SJ; Kim, S

Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea

Lee¹, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Celastrol attenuates the inflammatory response by inhibiting IL-1 beta expression in triple-negative breast cancer cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE; Kim, S

Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry

Kim¹, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH

The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW

Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer

Woo¹, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer

Min¹, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer

Kwon¹, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE

Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?

Jung¹, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

Park¹, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z

Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence

Lee¹, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI

ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer

Schabort¹, JJ; Nam, AR; Lee, KH; Kim, SW; Lee, JE; Cho, JY

WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

Jung¹, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE

Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer

Kim¹, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY

Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

Park¹, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH

Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients

Kim¹, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY

Impact of Serum Lipid on Breast Cancer Recurrence

Jung¹, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK

Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer

Kim¹, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study

Kim¹, J; Cho, J; Lee, SK; Choi, EK; Kim, IR; Lee, JE; Kim, SW; Nam, SJ

Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence

Ryu¹, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK

Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors

Ryu¹, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J

Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm

Alsharif¹, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK

A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment

Kwon¹, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?

Lee¹, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans

Kim¹, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients

Choi¹, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY

Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Ryu¹, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients

Hwang¹, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis

Choi¹, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer

Bae¹, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ

Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer

Ryu¹, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study

Choi¹, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort

Kim¹, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment

Cho¹, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S

Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype

Bae¹, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer

Kim¹, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?

Cho¹, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY

Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer

Park¹, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

Kan¹, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH

Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells

Jeong¹, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy

Park¹, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH

Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells

Kim¹, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane

Park¹, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ

Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast

Kim¹, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE

Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society

Ryu¹, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer

Woo¹, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY

Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis

Ryu¹, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy

Kim¹, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry

You¹, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy

Kim¹, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction

Jeon¹, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

Kim¹, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study

Ryu JM1¹, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy

Kim I1¹, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.

Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer

Park S1¹, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.

Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy

Yoon N¹, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

Conditional disease-free survival among patients with breast cancer

Paik HJ1¹, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.

Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer

Kim H1¹, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.

Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype

Alramadhan M1¹, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.

Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea

Kim HK1¹, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Ryu JM1¹, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.

Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series

Lee MY1¹, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.

Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm

Ryu JM1¹, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.

The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment

Kim JY¹, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer

Kim H1¹, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.

Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes

Kim SW1¹, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.

Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

Yoon N1¹, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.

Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Kim JY1¹, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.

Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer

Lee JY1¹, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.

Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery

Lee JH1¹, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.

Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer

Lee JY1¹, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.

Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Park K1¹, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.

Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation

Kim H1¹, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.

Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival

Lee SK1¹, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.

Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer

Lee SK1¹, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.

A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery

Park YH1¹, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.

Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer

Yu JI1¹, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.

Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer

Bae SY1¹, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.

Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study

Lee SK1¹, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.

Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis

Kim JY1¹, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.

Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology

Jung HA1¹, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Invasive Paget disease of the breast: 20 years of experience at a single institution

Lee HW1¹, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells

Kim S1¹, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.

Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells

Han J1¹, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.

Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy

Kim J1¹, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.

The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer

Lee SK1¹, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.

Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ

Lee JH1¹, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells

Kim S1¹, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.